|
TNPO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.051200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.198170E-01 |
| Normal-vs-Stage2 |
7.517400E-01 |
| Normal-vs-Stage3 |
8.914400E-01 |
| Normal-vs-Stage4 |
3.456200E-01 |
| Stage1-vs-Stage2 |
6.846000E-01 |
| Stage1-vs-Stage3 |
3.881800E-01 |
| Stage1-vs-Stage4 |
5.234600E-01 |
| Stage2-vs-Stage3 |
7.297000E-01 |
| Stage2-vs-Stage4 |
5.429000E-01 |
| Stage3-vs-Stage4 |
3.667600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.743400E-01 |
| Normal-vs-AfricanAmerican |
4.481400E-01 |
| Normal-vs-Asian |
4.983800E-01 |
| Caucasian-vs-AfricanAmerican |
8.369800E-01 |
| Caucasian-vs-Asian |
5.412800E-01 |
| AfricanAmerican-vs-Asian |
6.516800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.535500E-02 |
| Normal-vs-Female |
2.630000E-01 |
| Male-vs-Female |
1.670080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.753000E-01 |
| Normal-vs-Extreme_Weight |
2.095600E-02 |
| Normal-vs-Obese |
6.597200E-01 |
| Normal-vs-Extreme_Obese |
5.653800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.134200E-01 |
| Normal_Weight-vs-Obese |
3.578600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.167000E-01 |
| Extreme_Weight-vs-Obese |
3.456400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.750800E-01 |
| Obese-vs-Extreme_Obese |
4.455000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.485600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.643600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.519880E-02 |
| Normal-vs-Age(81-100Yrs) |
3.000100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.733700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.374800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.957800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.120900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.299700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.449600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.968400E-01 |
| Normal-VS-Type2 PRCC |
4.004400E-04 |
| Normal-VS-KIRP CIMP |
1.283220E-01 |
| Normal-VS-Unclassified PRCC |
3.572000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.634500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.148100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.399400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.229100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.556700E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.754380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.389150E-01 |
| Normal-vs-N1 |
7.445200E-01 |
| Normal-vs-N2 |
4.643200E-01 |
| N0-vs-N1 |
5.553200E-01 |
| N0-vs-N2 |
2.155200E-01 |
| N1-vs-N2 |
4.605000E-01 |
|
|
